Anne-Cathrine Østby
Clinical Associate Professor
1 - 1 out of 1Page size: 10
- 2021
- Published
Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—real world efficacy
Mouritzen, M. T., Carus, A., Ladekarl, M., Meldgaard, P., Nielsen, A. W. M., Livbjerg, A., Larsen, J. W., Skuladottir, H., Kristiansen, C., Wedervang, K., Schytte, T., Hansen, K. H., Østby, A. C., Frank, M. S., Lauritsen, J., Sørensen, J. B., Langer, S. W., Persson, G. F., Andersen, J. L., Frary, J. M. C. & 5 others, , 2021, In: Cancers. 13, 19, 4846.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 247668701
Most downloads
-
16
downloads
Nationwide survival benefit after implementation of first-line immunotherapy for patients with advanced nsclc—real world efficacy
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
11
downloads
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
Research output: Contribution to journal › Journal article › Research › peer-review
Published